Over the past few years, cardiopulmonary exercise testing (CPET) has been recognized as a vital clinical tool, used to assess exercise capacity in patients and predict various cardiac conditions. CPET provides the assessment of integrative exercise response including cardiovascular, pulmonary, and skeletal muscle systems. Since the developments in the technology, cardiopulmonary stress testing systems are being consistently used in many clinical applications.
Changes in the lifestyle, stressful life, and lack of exercise have led to the growing obese population. This has led to the growth of cardiac patients, which has, in turn, increased the acceptance of cardiopulmonary stress testing systems. Transparency Market Research (TMR), in its new report, states that the global cardiopulmonary stress testing systems market was valued at US$3.30 bn in 2014 and is predicted to reach US$6.67 bn by 2023, expected to progress at an 8.20% CAGR from 2015 to 2023.
TMR experts answer a few important questions based on the global cardiopulmonary stress testing systems, which the readers would like to know:
Q. How is obesity the most important driving factor for the global cardiopulmonary stress testing systems market?
The modern lifestyle and the increasing habit of eating junk food have led to significant growth of obese people. The increasing cases of obesity have led to the increase in cardiac disorders. Currently, North America records the highest number of obese people. However, the number of obese people is expected to increase in Asia Pacific in the years to come. The global rise in the obese people is expected to be the most important factor driving the global cardiopulmonary stress testing systems market.
Q. Will technology plan an important role in the development of the global market?
Yes, technology has helped towards the development of many industries, and the global cardiopulmonary stress testing systems market is not an exception. Technological advancements in cardiopulmonary stress testing systems have enhanced the functional parameters, which is likely to propel the global market. Key companies operating in the global cardiopulmonary stress testing systems market are aiming to adopt new technologies for the development of new systems.
Q. How will the global market be affected by the rising occurrence of cardiovascular diseases?
The occurrence of cardiovascular diseases is been increasing since the recent past, which has been one of the driving factors for the global market. As per the World Health Organization, the coronary artery disease accounts for 64% of the total global deaths occurring from cardiovascular conditions. This has thus been recognized as one of the primary causes of average quality of life for a majority of the global population.
It is always boosting to see researchers investing more towards the development of new products. Recently, a women’s special hospital in Boston showed interest in developing new cardiopulmonary stress testing systems.
With many leading players showing interest and efforts towards the development of new cardiopulmonary stress testing systems, the global market is expected to show promising growth opportunities across many regions. The presence of key equipment manufacturers of cardiopulmonary stress testing systems, the application of laws including the Affordable healthcare Act, and the high awareness among people are some of the factors expected to propel the global cardiopulmonary stress testing systems market in the near future.